Matches in Wikidata for { <http://www.wikidata.org/entity/Q89154478> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q89154478 description "assaig clínic" @default.
- Q89154478 description "clinical trial" @default.
- Q89154478 description "clinical trial" @default.
- Q89154478 description "clinical trial" @default.
- Q89154478 description "clinical trial" @default.
- Q89154478 description "ensaio clínico" @default.
- Q89154478 description "ensayo clínico" @default.
- Q89154478 description "ensayu clínicu" @default.
- Q89154478 description "essai clinique" @default.
- Q89154478 description "klinisch onderzoek" @default.
- Q89154478 description "клінічне випробування" @default.
- Q89154478 name "Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N" @default.
- Q89154478 name "Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N" @default.
- Q89154478 type Item @default.
- Q89154478 label "Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N" @default.
- Q89154478 label "Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N" @default.
- Q89154478 prefLabel "Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N" @default.
- Q89154478 prefLabel "Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N" @default.
- Q89154478 P1050 Q89154478-772CEB8B-7AB7-434E-9067-1DEC51D5551E @default.
- Q89154478 P1132 Q89154478-116D6802-AB50-4A6B-B65D-4126C8997517 @default.
- Q89154478 P1476 Q89154478-33717137-9F8A-41C6-9D55-C62A3B03AC57 @default.
- Q89154478 P17 Q89154478-AD61A59C-EDD9-4642-926D-AA666CB5177B @default.
- Q89154478 P2899 Q89154478-150D9E0A-3BDC-4A85-9F77-23E89DC445DB @default.
- Q89154478 P3098 Q89154478-AA5D9D6A-BF4E-4530-84CC-2516EDB8ED05 @default.
- Q89154478 P31 Q89154478-33677792-22BE-48F5-889C-FAB5EF430778 @default.
- Q89154478 P4844 Q89154478-C70B3217-E341-4842-8379-DF1FC3474BE1 @default.
- Q89154478 P580 Q89154478-031F39B0-8C58-4CDB-9FED-B9D122485B29 @default.
- Q89154478 P582 Q89154478-74EC41E0-10B8-44A5-9652-918BFF4E7FE7 @default.
- Q89154478 P6099 Q89154478-3FE8080B-0E0D-4548-B181-24CD0CC5811C @default.
- Q89154478 P8363 Q89154478-7C3867E2-6BF2-4B1C-A958-CCA65DD32300 @default.
- Q89154478 P1050 Q33525 @default.
- Q89154478 P1132 "+15" @default.
- Q89154478 P1476 "A Phase 1B, Single Arm Study of Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of the Head and Neck to Assess for Pathologic Responses in the Tumor Microenvironment" @default.
- Q89154478 P17 Q30 @default.
- Q89154478 P2899 "+18" @default.
- Q89154478 P3098 "NCT04323202" @default.
- Q89154478 P31 Q30612 @default.
- Q89154478 P4844 Q13896859 @default.
- Q89154478 P580 "2020-05-08T00:00:00Z" @default.
- Q89154478 P582 "2021-06-15T00:00:00Z" @default.
- Q89154478 P6099 Q5452194 @default.
- Q89154478 P8363 Q78089383 @default.